Quinn vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionQuinnIsomorphic Labs
PricingContact for pricing (custom per engagement)Contact for pricing (deep pharma partnerships only)
Target UserR&D teams at biotechs, pharma, academic spinoutsLarge pharma companies with partnership models
Core TechnologyAI synthesis of public/private data for drug development decisionsPredictive and generative AI models using AlphaFold
DeploymentAI-as-a-service with 30-min scoping call, output in 2–5 daysDeep collaborative partnerships on large-scale programs
Key IntegrationsNo integrations listedNo integrations listed
Latest News2026-06-29: Hacker News post about 'Quinn the Eskimo' wisdom repo2026-05-12: Series B investment round; 2026-01-20: J&J collaboration

Choose Quinn if you need actionable, defendable R&D decisions in days without committing to a long-term partnership. Choose Isomorphic Labs if you are a large pharma aiming to embed deep AI capabilities in your discovery pipeline via a strategic collaboration. They serve completely different needs—Quinn for agile decisions, Isomorphic for scale partnerships.

Quinn
Quinn

AI scientist delivering defendable drug program decisions in 2–5 days.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
4 views
7.4k views
Skill Level
Advanced
Advanced
API Available
Platforms
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Indication prioritization with ranked shortlists and scored rationale
Target and modality assessment (druggability, tractability, FTO)
Biomarker and patient selection from genomic/proteomic evidence
Clinical trial design (adaptive design, endpoint strategy, sample size)
Competitive intelligence synthesis and regulatory gap analysis
MoA elucidation and target identification
Lead optimization and CMC support
TPP and valuation summaries
Reproducible code and validation protocols
SOC 2 Type II certified
ISO 27001 certified
HIPAA compliant
Never trains on customer data
Supports any therapeutic area and modality
Discovery through commercialization support
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: Quinn vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Quinn

65 mentions across 3 sources · 22% positive — critical

Hacker News, App Store, Lemmy

What users praise

  • Targeted at high-stakes pharma decisions with structured outputs.
  • Covers full R&D lifecycle from discovery to commercialization.
  • Produces reproducible code and validation protocols.
  • SOC 2 Type II certified for data security.

What frustrates them

  • No independent user reviews available to verify claims.
  • Pricing is opaque with no free tier or trial.
  • Name collision with popular audio app may cause confusion.
  • 30-minute scoping call adds initial friction.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Solo founder
    Pick: Quinn

    Quinn provides fast, defendable decisions for drug development questions without requiring a partnership or large budget, ideal for early-stage biotech.

  • Large pharma R&D team
    Pick: Isomorphic Labs

    Isomorphic Labs offers deep integration into large-scale drug discovery pipelines via strategic collaborations, leveraging AlphaFold and AI models.

  • Translational scientist
    Pick: Quinn

    Quinn's target validation, biomarker selection, and MoA elucidation outputs are tailored for translational decision-making in a matter of days.

  • Biotech governance committee
    Pick: Quinn

    Quinn's scored shortlists and validation protocols support governance discussions for indication prioritization and program decisions.

  • Late-stage pipeline lead optimizer
    Pick: Isomorphic Labs

    Isomorphic's Drug Design Engine with predictive/generative models accelerates lead optimization at scale, suitable for large programs.

Frequently Asked Questions

Quinn vs Isomorphic Labs: which should you choose?

Choose Quinn if you need actionable, defendable R&D decisions in days without committing to a long-term partnership. Choose Isomorphic Labs if you are a large pharma aiming to embed deep AI capabilities in your discovery pipeline via a strategic collaboration. They serve completely different needs—Quinn for agile decisions, Isomorphic for scale partnerships.

What types of questions does Quinn answer?

Quinn answers drug development questions such as indication prioritization, target validation, biomarker selection, trial design, competitive intelligence, regulatory gaps, and MoA elucidation.

Can I use Isomorphic Labs as a small startup?

Isomorphic Labs partners exclusively with large pharma companies (Novartis, J&J) on large-scale programs; it is not designed for startups or individual researchers.

How long does Quinn take to deliver an analysis?

Quinn delivers structured outputs in 2–5 days after a 30-minute scoping call.

Does Isomorphic Labs provide a software API?

No, Isomorphic Labs operates through collaborative partnerships, not as a standalone API or software product.

Is Quinn HIPAA compliant?

Yes, Quinn is HIPAA compliant and SOC 2 Type II certified.

What is the latest funding news for Isomorphic Labs?

Isomorphic Labs raised a $600M external investment round in 2025 and closed a Series B in May 2026 (amount undisclosed).

Does Quinn train on customer data?

No, Quinn states it never trains on customer data.

Are there any free tiers for either tool?

No, both require contacting sales for pricing; no free tiers are available.

More Quinn or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026